{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:49:55Z","timestamp":1790614195168,"version":"4.1.0"},"publisher-location":"Cham","reference-count":112,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030259044","type":"print"},{"value":"9783030259051","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-25905-1_15","type":"book-chapter","created":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T21:02:41Z","timestamp":1570395761000},"page":"317-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nephrogenic Diabetes Insipidus"],"prefix":"10.1007","author":[{"given":"Andr\u00e1s","family":"Balla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Hunyady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"1","key":"15_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000166896","volume":"5","author":"U Alon","year":"1985","unstructured":"Alon U, Chan JC (1985) Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 5(1):9\u201313. https:\/\/doi.org\/10.1159\/000166896","journal-title":"Am J Nephrol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1 2 1","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger JS, Hamosh A (2017) Searching online mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinformatics 58:1 2 1\u20131 2 12. https:\/\/doi.org\/10.1002\/cpbi.27","journal-title":"Curr Protoc Bioinformatics"},{"issue":"2","key":"15_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.beem.2016.02.005","volume":"30","author":"S Ananthakrishnan","year":"2016","unstructured":"Ananthakrishnan S (2016) Diabetes insipidus during pregnancy. Best Pract Res Clin Endocrinol Metab 30(2):305\u2013315. https:\/\/doi.org\/10.1016\/j.beem.2016.02.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"15_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.18999\/nagjms.78.4.349","volume":"78","author":"H Arima","year":"2016","unstructured":"Arima H, Azuma Y, Morishita Y, Hagiwara D (2016) Central diabetes insipidus. Nagoya J Med Sci 78(4):349\u2013358. https:\/\/doi.org\/10.18999\/nagjms.78.4.349","journal-title":"Nagoya J Med Sci"},{"issue":"6","key":"15_CR5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1681\/ASN.V1161044","volume":"11","author":"MF Arthus","year":"2000","unstructured":"Arthus MF, Lonergan M, Crumley MJ et al (2000) Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11(6):1044\u20131054","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"15_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1681\/ASN.2004121079","volume":"16","author":"L Bankir","year":"2005","unstructured":"Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG (2005) Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16(7):1920\u20131928. https:\/\/doi.org\/10.1681\/ASN.2004121079","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"15_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1073\/pnas.011303698","volume":"98","author":"LS Barak","year":"2001","unstructured":"Barak LS, Oakley RH, Laporte SA, Caron MG (2001) Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A 98(1):93\u201398. https:\/\/doi.org\/10.1073\/pnas.011303698","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"15_CR8","doi-asserted-by":"publisher","first-page":"e13665","DOI":"10.14814\/phy2.13665","volume":"6","author":"AP Bech","year":"2018","unstructured":"Bech AP, Wetzels JFM, Nijenhuis T (2018) Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers. Physiol Rep 6(7):e13665. https:\/\/doi.org\/10.14814\/phy2.13665","journal-title":"Physiol Rep"},{"issue":"4","key":"15_CR9","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00554.2007","volume":"294","author":"JJ Bedford","year":"2008","unstructured":"Bedford JJ, Leader JP, Jing R, Walker LJ, Klein JD, Sands JM, Walker RJ (2008a) Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 294(4):F812\u2013F820. https:\/\/doi.org\/10.1152\/ajprenal.00554.2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"15_CR10","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2215\/CJN.01640408","volume":"3","author":"JJ Bedford","year":"2008","unstructured":"Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ (2008b) Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol 3(5):1324\u20131331. https:\/\/doi.org\/10.2215\/CJN.01640408","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"15_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2165\/00002018-199921060-00002","volume":"21","author":"H Bendz","year":"1999","unstructured":"Bendz H, Aurell M (1999) Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 21(6):449\u2013456. https:\/\/doi.org\/10.2165\/00002018-199921060-00002","journal-title":"Drug Saf"},{"issue":"8","key":"15_CR12","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1210\/me.2004-0080","volume":"18","author":"V Bernier","year":"2004","unstructured":"Bernier V, Lagace M, Lonergan M, Arthus MF, Bichet DG, Bouvier M (2004) Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol 18(8):2074\u20132084. https:\/\/doi.org\/10.1210\/me.2004-0080","journal-title":"Mol Endocrinol"},{"issue":"1","key":"15_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1681\/ASN.2005080854","volume":"17","author":"V Bernier","year":"2006","unstructured":"Bernier V, Morello JP, Zarruk A et al (2006) Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17(1):232\u2013243. https:\/\/doi.org\/10.1681\/ASN.2005080854","journal-title":"J Am Soc Nephrol"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1877-1173(09)89002-9","volume":"89","author":"DG Bichet","year":"2009","unstructured":"Bichet DG (2009) V2R mutations and nephrogenic diabetes insipidus. Prog Mol Biol Transl Sci 89:15\u201329. https:\/\/doi.org\/10.1016\/S1877-1173(09)89002-9","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"15_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.beem.2016.02.010","volume":"30","author":"DG Bichet","year":"2016","unstructured":"Bichet DG, Bockenhauer D (2016) Genetic forms of nephrogenic diabetes insipidus (NDI): vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 30(2):263\u2013276. https:\/\/doi.org\/10.1016\/j.beem.2016.02.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"14","key":"15_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM198804073181403","volume":"318","author":"DG Bichet","year":"1988","unstructured":"Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN (1988) Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. New Engl J Med 318(14):881\u2013887. https:\/\/doi.org\/10.1056\/NEJM198804073181403","journal-title":"New Engl J Med"},{"issue":"5","key":"15_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ki.1989.272","volume":"36","author":"DG Bichet","year":"1989","unstructured":"Bichet DG, Razi M, Arthus MF et al (1989) Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism. Kidney Int 36(5):859\u2013866","journal-title":"Kidney Int"},{"issue":"6376","key":"15_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/357333a0","volume":"357","author":"M Birnbaumer","year":"1992","unstructured":"Birnbaumer M, Seibold A, Gilbert S et al (1992) Molecular cloning of the receptor for human antidiuretic hormone. Nature 357(6376):333\u2013335. https:\/\/doi.org\/10.1038\/357333a0","journal-title":"Nature"},{"issue":"8","key":"15_CR19","doi-asserted-by":"publisher","first-page":"F1037","DOI":"10.1152\/ajprenal.00639.2012","volume":"304","author":"D Bockenhauer","year":"2013","unstructured":"Bockenhauer D, Bichet DG (2013) Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. Am J Physiol Renal Physiol 304(8):F1037\u2013F1042. https:\/\/doi.org\/10.1152\/ajprenal.00639.2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"15_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MOP.0000000000000473","volume":"29","author":"D Bockenhauer","year":"2017","unstructured":"Bockenhauer D, Bichet DG (2017) Nephrogenic diabetes insipidus. Curr Opin Pediatr 29(2):199\u2013205. https:\/\/doi.org\/10.1097\/MOP.0000000000000473","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"15_CR21","doi-asserted-by":"publisher","first-page":"F1103","DOI":"10.1152\/ajprenal.00337.2004","volume":"288","author":"R Bouley","year":"2005","unstructured":"Bouley R, Pastor-Soler N, Cohen O et al (2005) Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra). Am J Physiol Renal Physiol 288(6):F1103\u2013F1112. https:\/\/doi.org\/10.1152\/ajprenal.00337.2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"15_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0090-4295(80)90039-4","volume":"16","author":"SD Boyd","year":"1980","unstructured":"Boyd SD, Raz S, Ehrlich RM (1980) Diabetes insipidus and nonobstructive dilation of urinary tract. Urology 16(3):266\u2013269","journal-title":"Urology"},{"issue":"11","key":"15_CR23","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/hmg\/6.11.1865","volume":"6","author":"MC Canfield","year":"1997","unstructured":"Canfield MC, Tamarappoo BK, Moses AM, Verkman AS, Holtzman EJ (1997) Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 6(11):1865\u20131871","journal-title":"Hum Mol Genet"},{"issue":"10","key":"15_CR24","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1681\/ASN.2012010077","volume":"23","author":"E Carpentier","year":"2012","unstructured":"Carpentier E, Greenbaum LA, Rochdi D et al (2012) Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD. J Am Soc Nephrol 23(10):1635\u20131640. https:\/\/doi.org\/10.1681\/ASN.2012010077","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"15_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.gim.0000223554.46981.7a","volume":"8","author":"P Carroll","year":"2006","unstructured":"Carroll P, Al-Mojalli H, Al-Abbad A et al (2006) Novel mutations underlying nephrogenic diabetes insipidus in Arab families. Genet Med 8(7):443\u2013447","journal-title":"Genet Med"},{"issue":"5","key":"15_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1124\/mol.114.092817","volume":"86","author":"H Cernecka","year":"2014","unstructured":"Cernecka H, Sand C, Michel MC (2014) The odd sibling: features of beta3-adrenoceptor pharmacology. Mol Pharmacol 86(5):479\u2013484. https:\/\/doi.org\/10.1124\/mol.114.092817","journal-title":"Mol Pharmacol"},{"issue":"1","key":"15_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/nau.22505","volume":"33","author":"CR Chapple","year":"2014","unstructured":"Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC (2014) Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 33(1):17\u201330. https:\/\/doi.org\/10.1002\/nau.22505","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"15_CR28","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1681\/ASN.2015080903","volume":"27","author":"PW Cheung","year":"2016","unstructured":"Cheung PW, Nomura N, Nair AV et al (2016) EGF receptor inhibition by erlotinib increases aquaporin 2-mediated renal water reabsorption. J Am Soc Nephrol 27(10):3105\u20133116. https:\/\/doi.org\/10.1681\/ASN.2015080903","journal-title":"J Am Soc Nephrol"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1172\/JCI105038","volume":"43","author":"JW Czaczkes","year":"1964","unstructured":"Czaczkes JW, Kleeman CR, Koenig M (1964) Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J Clin Invest 43:1625\u20131640. https:\/\/doi.org\/10.1172\/JCI105038","journal-title":"J Clin Invest"},{"issue":"24","key":"15_CR30","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/hmg\/ddh339","volume":"13","author":"F Mattia de","year":"2004","unstructured":"de Mattia F, Savelkoul PJ, Bichet DG et al (2004) A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L. Hum Mol Genet 13(24):3045\u20133056. https:\/\/doi.org\/10.1093\/hmg\/ddh339","journal-title":"Hum Mol Genet"},{"issue":"2","key":"15_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1681\/ASN.2006090987","volume":"18","author":"G Decaux","year":"2007","unstructured":"Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C (2007) Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18(2):606\u2013612. https:\/\/doi.org\/10.1681\/ASN.2006090987","journal-title":"J Am Soc Nephrol"},{"issue":"5155","key":"15_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8140421","volume":"264","author":"PM Deen","year":"1994","unstructured":"Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA (1994) Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264(5155):92\u201395","journal-title":"Science"},{"issue":"2","key":"15_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","volume":"77","author":"N Iorgi Di","year":"2012","unstructured":"Di Iorgi N, Napoli F, Allegri AE et al (2012) Diabetes insipidus\u2013diagnosis and management. Horm Res Paediatr 77(2):69\u201384. https:\/\/doi.org\/10.1159\/000336333","journal-title":"Horm Res Paediatr"},{"issue":"19","key":"15_CR34","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1073\/pnas.91.19.8984","volume":"91","author":"SR DiGiovanni","year":"1994","unstructured":"DiGiovanni SR, Nielsen S, Christensen EI, Knepper MA (1994) Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A 91(19):8984\u20138988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"15_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/exnr.2001.7775","volume":"171","author":"CA Ecelbarger","year":"2001","unstructured":"Ecelbarger CA, Kim GH, Wade JB, Knepper MA (2001) Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol 171(2):227\u2013234. https:\/\/doi.org\/10.1006\/exnr.2001.7775","journal-title":"Exp Neurol"},{"issue":"3","key":"15_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrm1052","volume":"4","author":"L Ellgaard","year":"2003","unstructured":"Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4(3):181\u2013191. https:\/\/doi.org\/10.1038\/nrm1052","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"15_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1210\/me.2013-1424","volume":"28","author":"LS Erdelyi","year":"2014","unstructured":"Erdelyi LS, Balla A, Patocs A, Toth M, Varnai P, Hunyady L (2014) Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. Mol Endocrinol 28(5):634\u2013643. https:\/\/doi.org\/10.1210\/me.2013-1424","journal-title":"Mol Endocrinol"},{"issue":"5","key":"15_CR38","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ki.2015.181","volume":"88","author":"LS Erdelyi","year":"2015","unstructured":"Erdelyi LS, Mann WA, Morris-Rosendahl DJ et al (2015) Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis. Kidney Int 88(5):1070\u20131078. https:\/\/doi.org\/10.1038\/ki.2015.181","journal-title":"Kidney Int"},{"issue":"18","key":"15_CR39","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1056\/NEJMoa042743","volume":"352","author":"BJ Feldman","year":"2005","unstructured":"Feldman BJ, Rosenthal SM, Vargas GA et al (2005) Nephrogenic syndrome of inappropriate antidiuresis. New Engl J Med 352(18):1884\u20131890. https:\/\/doi.org\/10.1056\/NEJMoa042743","journal-title":"New Engl J Med"},{"issue":"10","key":"15_CR40","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2012-1981","volume":"97","author":"W Fenske","year":"2012","unstructured":"Fenske W, Allolio B (2012) Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab 97(10):3426\u20133437. https:\/\/doi.org\/10.1210\/jc.2012-1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"15_CR41","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1152\/physrev.00053.2006","volume":"87","author":"RA Fenton","year":"2007","unstructured":"Fenton RA, Knepper MA (2007) Mouse models and the urinary concentrating mechanism in the new millennium. Physiol Rev 87(4):1083\u20131112. https:\/\/doi.org\/10.1152\/physrev.00053.2006","journal-title":"Physiol Rev"},{"issue":"1","key":"15_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0006-8993(85)91351-4","volume":"342","author":"E Fliers","year":"1985","unstructured":"Fliers E, Swaab DF, Pool CW, Verwer RW (1985) The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia. Brain Res 342(1):45\u201353","journal-title":"Brain Res"},{"issue":"17","key":"15_CR43","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1073\/pnas.1321406111","volume":"111","author":"A Frick","year":"2014","unstructured":"Frick A, Eriksson UK, de Mattia F et al (2014) X-ray structure of human aquaporin 2 and its implications for nephrogenic diabetes insipidus and trafficking. Proc Natl Acad Sci U S A 111(17):6305\u20136310. https:\/\/doi.org\/10.1073\/pnas.1321406111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"15_CR44","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1681\/ASN.2005040371","volume":"16","author":"TM Fujiwara","year":"2005","unstructured":"Fujiwara TM, Bichet DG (2005) Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol 16(10):2836\u20132846. https:\/\/doi.org\/10.1681\/ASN.2005040371","journal-title":"J Am Soc Nephrol"},{"issue":"27","key":"15_CR45","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1073\/pnas.1509565112","volume":"112","author":"M Gao","year":"2015","unstructured":"Gao M, Cao R, Du S et al (2015) Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts. Proc Natl Acad Sci U S A 112(27):8397\u20138402. https:\/\/doi.org\/10.1073\/pnas.1509565112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR46","first-page":"270","volume":"25","author":"SD Ichaliotis","year":"1965","unstructured":"Ichaliotis SD, Lambrinopoulos TC (1965) Serum oxytocinase in twin pregnancy. Obstet Gynecol 25:270\u2013272","journal-title":"Obstet Gynecol"},{"issue":"10","key":"15_CR47","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1681\/ASN.2008121289","volume":"20","author":"F Jean-Alphonse","year":"2009","unstructured":"Jean-Alphonse F, Perkovska S, Frantz MC et al (2009) Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 20(10):2190\u20132203. https:\/\/doi.org\/10.1681\/ASN.2008121289","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"15_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11102-007-0006-1","volume":"10","author":"I Kalelioglu","year":"2007","unstructured":"Kalelioglu I, Kubat Uzum A, Yildirim A, Ozkan T, Gungor F, Has R (2007) Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery. Pituitary 10(1):87\u201393. https:\/\/doi.org\/10.1007\/s11102-007-0006-1","journal-title":"Pituitary"},{"issue":"1","key":"15_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2230-8210.172273","volume":"20","author":"S Kalra","year":"2016","unstructured":"Kalra S, Zargar AH, Jain SM et al (2016) Diabetes insipidus: the other diabetes. Indian J Endocrinol Metab 20(1):9\u201321. https:\/\/doi.org\/10.4103\/2230-8210.172273","journal-title":"Indian J Endocrinol Metab"},{"issue":"9","key":"15_CR50","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1093\/emboj\/18.9.2394","volume":"18","author":"EJ Kamsteeg","year":"1999","unstructured":"Kamsteeg EJ, Wormhoudt TA, Rijss JP, van Os CH, Deen PM (1999) An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 18(9):2394\u20132400. https:\/\/doi.org\/10.1093\/emboj\/18.9.2394","journal-title":"EMBO J"},{"issue":"48","key":"15_CR51","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1073\/pnas.0604073103","volume":"103","author":"EJ Kamsteeg","year":"2006","unstructured":"Kamsteeg EJ, Hendriks G, Boone M, Konings IB, Oorschot V, van der Sluijs P, Klumperman J, Deen PM (2006) Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel. Proc Natl Acad Sci U S A 103(48):18344\u201318349. https:\/\/doi.org\/10.1073\/pnas.0604073103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"15_CR52","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1523-1755.2002.00210.x","volume":"61","author":"JD Klein","year":"2002","unstructured":"Klein JD, Gunn RB, Roberts BR, Sands JM (2002) Down-regulation of urea transporters in the renal inner medulla of lithium-fed rats. Kidney Int 61(3):995\u20131002. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00210.x","journal-title":"Kidney Int"},{"issue":"10","key":"15_CR53","doi-asserted-by":"publisher","first-page":"F1008","DOI":"10.1152\/ajprenal.00102.2016","volume":"310","author":"JD Klein","year":"2016","unstructured":"Klein JD, Wang Y, Blount MA, Molina PA, LaRocque LM, Ruiz JA, Sands JM (2016) Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol 310(10):F1008\u2013F1012. https:\/\/doi.org\/10.1152\/ajprenal.00102.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"15_CR54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/acta.0.1230657","volume":"123","author":"M Kocak","year":"1990","unstructured":"Kocak M, Karademir BM, Tetiker T (1990) Antidiuretic effect of indapamide in central diabetes insipidus. Acta Endocrinol (Copenh) 123(6):657\u2013660","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"15_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1210\/me.2008-0321","volume":"23","author":"M Kocan","year":"2009","unstructured":"Kocan M, See HB, Sampaio NG, Eidne KA, Feldman BJ, Pfleger KD (2009) Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23(4):559\u2013571. https:\/\/doi.org\/10.1210\/me.2008-0321","journal-title":"Mol Endocrinol"},{"issue":"1","key":"15_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ki.2009.91","volume":"76","author":"ML Kortenoeven","year":"2009","unstructured":"Kortenoeven ML, Li Y, Shaw S, Gaeggeler HP, Rossier BC, Wetzels JF, Deen PM (2009) Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int 76(1):44\u201353. https:\/\/doi.org\/10.1038\/ki.2009.91","journal-title":"Kidney Int"},{"issue":"11","key":"15_CR57","doi-asserted-by":"publisher","first-page":"F1395","DOI":"10.1152\/ajprenal.00376.2011","volume":"302","author":"ML Kortenoeven","year":"2012","unstructured":"Kortenoeven ML, Trimpert C, van den Brand M, Li Y, Wetzels JF, Deen PM (2012) In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac. Am J Physiol Renal Physiol 302(11):F1395\u2013F1401. https:\/\/doi.org\/10.1152\/ajprenal.00376.2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"15_CR58","doi-asserted-by":"publisher","first-page":"F1705","DOI":"10.1152\/ajprenal.00723.2012","volume":"305","author":"ML Kortenoeven","year":"2013","unstructured":"Kortenoeven ML, Sinke AP, Hadrup N, Trimpert C, Wetzels JF, Fenton RA, Deen PM (2013) Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla. Am J Physiol Renal Physiol 305(12):F1705\u2013F1718. https:\/\/doi.org\/10.1152\/ajprenal.00723.2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"15_CR59","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.2000.279.3.F552","volume":"279","author":"TH Kwon","year":"2000","unstructured":"Kwon TH, Laursen UH, Marples D, Maunsbach AB, Knepper MA, Frokiaer J, Nielsen S (2000) Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol 279(3):F552\u2013F564. https:\/\/doi.org\/10.1152\/ajprenal.2000.279.3.F552","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-540-79885-9_5","volume":"190","author":"TH Kwon","year":"2009","unstructured":"Kwon TH, Nielsen J, Moller HB, Fenton RA, Nielsen S, Frokiaer J (2009) Aquaporins in the kidney. Handb Exp Pharmacol 190:95\u2013132. https:\/\/doi.org\/10.1007\/978-3-540-79885-9_5","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"15_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajmg.1320380120","volume":"38","author":"JM Langley","year":"1991","unstructured":"Langley JM, Balfe JW, Selander T, Ray PN, Clarke JT (1991) Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet 38(1):90\u201394. https:\/\/doi.org\/10.1002\/ajmg.1320380120","journal-title":"Am J Med Genet"},{"issue":"4","key":"15_CR62","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1681\/ASN.2005080884","volume":"17","author":"Y Li","year":"2006","unstructured":"Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PM (2006) Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol 17(4):1063\u20131072. https:\/\/doi.org\/10.1681\/ASN.2005080884","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"15_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0022-3476(86)81010-1","volume":"108","author":"S Libber","year":"1986","unstructured":"Libber S, Harrison H, Spector D (1986) Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108(2):305\u2013311","journal-title":"J Pediatr"},{"issue":"4","key":"15_CR64","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1172\/JCI117863","volume":"95","author":"D Marples","year":"1995","unstructured":"Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S (1995) Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95(4):1838\u20131845. https:\/\/doi.org\/10.1172\/JCI117863","journal-title":"J Clin Invest"},{"issue":"1","key":"15_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s004240000498","volume":"442","author":"N Marr","year":"2001","unstructured":"Marr N, Kamsteeg EJ, van Raak M, van Os CH, Deen PM (2001) Functionality of aquaporin-2 missense mutants in recessive nephrogenic diabetes insipidus. Pflugers Arch 442(1):73\u201377. https:\/\/doi.org\/10.1007\/s004240000498","journal-title":"Pflugers Arch"},{"issue":"9","key":"15_CR66","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1097\/01.ASN.0000027355.41663.14","volume":"13","author":"N Marr","year":"2002","unstructured":"Marr N, Bichet DG, Hoefs S et al (2002) Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus. J Am Soc Nephrol 13(9):2267\u20132277","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"15_CR67","first-page":"289","volume":"47","author":"AE Meinders","year":"1974","unstructured":"Meinders AE, Cejka V, Robertson GL (1974) The antidiuretic action of carbamazepine in man. Clin Sci Mol Med 47(4):289\u2013299","journal-title":"Clin Sci Mol Med"},{"issue":"2","key":"15_CR68","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2012-1044","volume":"34","author":"HB Moeller","year":"2013","unstructured":"Moeller HB, Rittig S, Fenton RA (2013) Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev 34(2):278\u2013301. https:\/\/doi.org\/10.1210\/er.2012-1044","journal-title":"Endocr Rev"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","volume":"63","author":"JP Morello","year":"2001","unstructured":"Morello JP, Bichet DG (2001) Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607\u2013630. https:\/\/doi.org\/10.1146\/annurev.physiol.63.1.607","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"15_CR70","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1172\/JCI8688","volume":"105","author":"JP Morello","year":"2000","unstructured":"Morello JP, Salahpour A, Laperriere A et al (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105(7):887\u2013895. https:\/\/doi.org\/10.1172\/JCI8688","journal-title":"J Clin Invest"},{"issue":"3","key":"15_CR71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1172\/JCI107213","volume":"52","author":"AM Moses","year":"1973","unstructured":"Moses AM, Howanitz J, van Gemert M, Miller M (1973) Clofibrate-induced antidiuresis. J Clin Invest 52(3):535\u2013542. https:\/\/doi.org\/10.1172\/JCI107213","journal-title":"J Clin Invest"},{"issue":"2","key":"15_CR72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1681\/ASN.V82242","volume":"8","author":"SM Mulders","year":"1997","unstructured":"Mulders SM, Knoers NV, Van Lieburg AF et al (1997) New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 8(2):242\u2013248","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"15_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI2605","volume":"102","author":"SM Mulders","year":"1998","unstructured":"Mulders SM, Bichet DG, Rijss JP et al (1998) An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 102(1):57\u201366. https:\/\/doi.org\/10.1172\/JCI2605","journal-title":"J Clin Invest"},{"issue":"1","key":"15_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1152\/physrev.00024.2001","volume":"82","author":"S Nielsen","year":"2002","unstructured":"Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA (2002) Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82(1):205\u2013244. https:\/\/doi.org\/10.1152\/physrev.00024.2001","journal-title":"Physiol Rev"},{"issue":"3","key":"15_CR75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.semnephrol.2008.03.002","volume":"28","author":"J Nielsen","year":"2008","unstructured":"Nielsen J, Kwon TH, Christensen BM, Frokiaer J, Nielsen S (2008) Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus. Semin Nephrol 28(3):227\u2013244. https:\/\/doi.org\/10.1016\/j.semnephrol.2008.03.002","journal-title":"Semin Nephrol"},{"issue":"10","key":"15_CR76","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1210\/jcem.82.10.4312","volume":"82","author":"Y Nomura","year":"1997","unstructured":"Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, Morikawa A (1997) Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82(10):3434\u20133437. https:\/\/doi.org\/10.1210\/jcem.82.10.4312","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR77","first-page":"559","volume":"86","author":"NJ O'Doherty","year":"1962","unstructured":"O'Doherty NJ, Rosser J, Slater RJ (1962) Diabetes insipidus: the influence of chlorothiazide therapy in affected children. Can Med Assoc J 86:559\u2013567","journal-title":"Can Med Assoc J"},{"issue":"1","key":"15_CR78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2215\/CJN.05760513","volume":"10","author":"D Pearce","year":"2015","unstructured":"Pearce D, Soundararajan R, Trimpert C, Kashlan OB, Deen PM, Kohan DE (2015) Collecting duct principal cell transport processes and their regulation. Clin J Am Soc Nephrol 10(1):135\u2013146. https:\/\/doi.org\/10.2215\/CJN.05760513","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"15_CR79","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.kint.2016.03.020","volume":"90","author":"G Procino","year":"2016","unstructured":"Procino G, Carmosino M, Milano S et al (2016) beta3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function. Kidney Int 90(3):555\u2013567. https:\/\/doi.org\/10.1016\/j.kint.2016.03.020","journal-title":"Kidney Int"},{"issue":"3","key":"15_CR80","first-page":"322","volume":"67","author":"JP Rado","year":"1976","unstructured":"Rado JP (1976) Decreased antidiuretic response in diabetes insipidus during prolonged treatment with carbamazepine presumably due to enzym-induction. Endokrinologie 67(3):322\u2013330","journal-title":"Endokrinologie"},{"issue":"3","key":"15_CR81","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2265.2008.03513.x","volume":"71","author":"SA Ranadive","year":"2009","unstructured":"Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, Miller WL, Vaisse C (2009) Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol 71(3):388\u2013393. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03513.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"15_CR82","doi-asserted-by":"publisher","first-page":"F257","DOI":"10.1152\/ajprenal.00491.2005","volume":"291","author":"JH Robben","year":"2006","unstructured":"Robben JH, Knoers NV, Deen PM (2006) Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 291(2):F257\u2013F270. https:\/\/doi.org\/10.1152\/ajprenal.00491.2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"15_CR83","doi-asserted-by":"publisher","first-page":"F253","DOI":"10.1152\/ajprenal.00247.2006","volume":"292","author":"JH Robben","year":"2007","unstructured":"Robben JH, Sze M, Knoers NV, Deen PM (2007) Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 292(1):F253\u2013F260. https:\/\/doi.org\/10.1152\/ajprenal.00247.2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"29","key":"15_CR84","doi-asserted-by":"publisher","first-page":"12195","DOI":"10.1073\/pnas.0900130106","volume":"106","author":"JH Robben","year":"2009","unstructured":"Robben JH, Kortenoeven ML, Sze M et al (2009) Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci U S A 106(29):12195\u201312200. https:\/\/doi.org\/10.1073\/pnas.0900130106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.me.39.020188.002233","volume":"39","author":"GL Robertson","year":"1988","unstructured":"Robertson GL (1988) Differential diagnosis of polyuria. Annu Rev Med 39:425\u2013442. https:\/\/doi.org\/10.1146\/annurev.me.39.020188.002233","journal-title":"Annu Rev Med"},{"issue":"3","key":"15_CR86","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","volume":"24","author":"GL Robertson","year":"1995","unstructured":"Robertson GL (1995) Diabetes insipidus. Endocrinol Metab Clin N Am 24(3):549\u2013572","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"15_CR87","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","volume":"30","author":"GL Robertson","year":"2001","unstructured":"Robertson GL (2001) Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin N Am 30(3):671\u2013694, vii","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"6392","key":"15_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/359233a0","volume":"359","author":"W Rosenthal","year":"1992","unstructured":"Rosenthal W, Seibold A, Antaramian A et al (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359(6392):233\u2013235. https:\/\/doi.org\/10.1038\/359233a0","journal-title":"Nature"},{"issue":"18","key":"15_CR89","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(19)38614-4","volume":"268","author":"W Rosenthal","year":"1993","unstructured":"Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M (1993) Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 268(18):13030\u201313033","journal-title":"J Biol Chem"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"w14514","DOI":"10.4414\/smw.2017.14514","volume":"147","author":"C Sailer","year":"2017","unstructured":"Sailer C, Winzeler B, Christ-Crain M (2017) Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy. Swiss Med Wkly 147:w14514. https:\/\/doi.org\/10.4414\/smw.2017.14514","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"15_CR91","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jjcc.2010.08.001","volume":"56","author":"Y Saito","year":"2010","unstructured":"Saito Y (2010) Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol 56(3):262\u2013270. https:\/\/doi.org\/10.1016\/j.jjcc.2010.08.001","journal-title":"J Cardiol"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-physiol-021113-170350","volume":"76","author":"JM Sands","year":"2014","unstructured":"Sands JM, Layton HE (2014) Advances in understanding the urine-concentrating mechanism. Annu Rev Physiol 76:387\u2013409. https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170350","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"15_CR93","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2004.08.008","volume":"104","author":"T Schoneberg","year":"2004","unstructured":"Schoneberg T, Schulz A, Biebermann H, Hermsdorf T, Rompler H, Sangkuhl K (2004) Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104(3):173\u2013206. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.08.008","journal-title":"Pharmacol Ther"},{"issue":"1\u20132","key":"15_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0167-0115(93)90184-A","volume":"45","author":"A Seibold","year":"1993","unstructured":"Seibold A, Rosenthal W, Bichet DG, Birnbaumer M (1993) The vasopressin type 2 receptor gene. Chromosomal localization and its role in nephrogenic diabetes insipidus. Regul Pept 45(1\u20132):67\u201371","journal-title":"Regul Pept"},{"issue":"3","key":"15_CR95","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/ndt\/gfg574","volume":"19","author":"H Shalev","year":"2004","unstructured":"Shalev H, Romanovsky I, Knoers NV, Lupa S, Landau D (2004) Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 19(3):608\u2013613","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"15_CR96","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1530\/EJE-09-1057","volume":"162","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Thompson CJ (2010) The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol 162(Suppl 1):S13\u2013S18. https:\/\/doi.org\/10.1530\/EJE-09-1057","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"15_CR97","doi-asserted-by":"publisher","first-page":"679","DOI":"10.7326\/0003-4819-79-5-679","volume":"79","author":"I Singer","year":"1973","unstructured":"Singer I, Rotenberg D (1973) Demeclocycline-induced nephrogenic diabetes insipidus. In-vivo and in-vitro studies. Ann Intern Med 79(5):679\u2013683","journal-title":"Ann Intern Med"},{"issue":"4","key":"15_CR98","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1152\/physrev.1983.63.4.1243","volume":"63","author":"AH Sklar","year":"1983","unstructured":"Sklar AH, Schrier RW (1983) Central nervous system mediators of vasopressin release. Physiol Rev 63(4):1243\u20131280. https:\/\/doi.org\/10.1152\/physrev.1983.63.4.1243","journal-title":"Physiol Rev"},{"issue":"3","key":"15_CR99","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcp.21552","volume":"217","author":"E Spanakis","year":"2008","unstructured":"Spanakis E, Milord E, Gragnoli C (2008) AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol 217(3):605\u2013617. https:\/\/doi.org\/10.1002\/jcp.21552","journal-title":"J Cell Physiol"},{"issue":"10","key":"15_CR100","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1172\/JCI2303","volume":"101","author":"BK Tamarappoo","year":"1998","unstructured":"Tamarappoo BK, Verkman AS (1998) Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 101(10):2257\u20132267. https:\/\/doi.org\/10.1172\/JCI2303","journal-title":"J Clin Invest"},{"issue":"3","key":"15_CR101","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.pharmthera.2006.02.008","volume":"111","author":"YX Tao","year":"2006","unstructured":"Tao YX (2006) Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharm Ther 111(3):949\u2013973. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.02.008","journal-title":"Pharm Ther"},{"issue":"1","key":"15_CR102","first-page":"443","volume":"289","author":"K Thomsen","year":"1999","unstructured":"Thomsen K, Bak M, Shirley DG (1999) Chronic lithium treatment inhibits amiloride-sensitive sodium transport in the rat distal nephron. J Pharmacol Exp Ther 289(1):443\u2013447","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"15_CR103","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1210\/me.2016-1002","volume":"30","author":"A Tiulpakov","year":"2016","unstructured":"Tiulpakov A, White CW, Abhayawardana RS et al (2016) Mutations of vasopressin receptor 2 including novel L312S have differential effects on trafficking. Mol Endocrinol 30(8):889\u2013904. https:\/\/doi.org\/10.1210\/me.2016-1002","journal-title":"Mol Endocrinol"},{"issue":"8","key":"15_CR104","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bbamem.2006.06.001","volume":"1758","author":"F Umenishi","year":"2006","unstructured":"Umenishi F, Narikiyo T, Vandewalle A, Schrier RW (2006) cAMP regulates vasopressin-induced AQP2 expression via protein kinase A-independent pathway. Biochim Biophys Acta 1758(8):1100\u20131105. https:\/\/doi.org\/10.1016\/j.bbamem.2006.06.001","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"15_CR105","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.V1091958","volume":"10","author":"AF Lieburg van","year":"1999","unstructured":"van Lieburg AF, Knoers NV, Monnens LA (1999) Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 10(9):1958\u20131964","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"15_CR106","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1530\/acta.0.0680725","volume":"68","author":"JK Wales","year":"1971","unstructured":"Wales JK, Fraser TR (1971) The clinical use of chlorpropamide in diabetes insipidus. Acta Endocrinol (Copeng) 68(4):725\u2013736","journal-title":"Acta Endocrinol (Copeng)"},{"issue":"10","key":"15_CR107","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1681\/ASN.2015050592","volume":"27","author":"F Wang","year":"2016","unstructured":"Wang F, Lu X, Peng K et al (2016) Antidiuretic action of collecting duct (pro)renin receptor downstream of vasopressin and PGE2 receptor EP4. J Am Soc Nephrol 27(10):3022\u20133034. https:\/\/doi.org\/10.1681\/ASN.2015050592","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"15_CR108","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/00007611-199012000-00026","volume":"83","author":"RS Weinstock","year":"1990","unstructured":"Weinstock RS, Moses AM (1990) Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate. South Med J 83(12):1475\u20131477","journal-title":"South Med J"},{"issue":"12","key":"15_CR109","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00467-012-2118-8","volume":"27","author":"D Wesche","year":"2012","unstructured":"Wesche D, Deen PM, Knoers NV (2012) Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 27(12):2183\u20132204. https:\/\/doi.org\/10.1007\/s00467-012-2118-8","journal-title":"Pediatr Nephrol"},{"issue":"40","key":"15_CR110","doi-asserted-by":"publisher","first-page":"11981","DOI":"10.1021\/bi020275m","volume":"41","author":"AM Wilbanks","year":"2002","unstructured":"Wilbanks AM, Laporte SA, Bohn LM, Barak LS, Caron MG (2002) Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry 41(40):11981\u201311989","journal-title":"Biochemistry"},{"issue":"45","key":"15_CR111","doi-asserted-by":"publisher","first-page":"47254","DOI":"10.1074\/jbc.M408154200","volume":"279","author":"S Wuller","year":"2004","unstructured":"Wuller S, Wiesner B, Loffler A et al (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem 279(45):47254\u201347263. https:\/\/doi.org\/10.1074\/jbc.M408154200","journal-title":"J Biol Chem"},{"issue":"4","key":"15_CR112","first-page":"381","volume":"9","author":"D Zimmerman","year":"1975","unstructured":"Zimmerman D, Green OC (1975) Nephrogenic diabetes-insipidus - type-II- defect distal to adenylate cyclase step. Pediatr Res 9(4):381\u2013381","journal-title":"Pediatr Res"}],"container-title":["Experientia Supplementum","Genetics of Endocrine Diseases and Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-25905-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T02:27:57Z","timestamp":1664591277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-25905-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030259044","9783030259051"],"references-count":112,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-25905-1_15","relation":{},"ISSN":["1664-431X","2504-3692"],"issn-type":[{"value":"1664-431X","type":"print"},{"value":"2504-3692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}